1. Mangiferin Improves Hepatic Lipid Metabolism Mainly Through Its Metabolite-Norathyriol by Modulating SIRT-1/AMPK/SREBP-1c Signaling
   Jian Li et al, 2018, Front. Pharmacol. CrossRef
2. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease
   Jia-Min Yang et al, 2019, WJG CrossRef
3. The Impacts of Herbal Medicines and Natural Products on Regulating the Hepatic Lipid Metabolism
   Sha Li et al, 2020, Front. Pharmacol. CrossRef
4. Mechanism and Basis of Traditional Chinese Medicine Against Obesity: Prevention and Treatment Strategies
   Chang-hua Zhang et al, 2021, Front. Pharmacol. CrossRef
5. Constituents, Pharmacokinetics, and Pharmacology of Gegen-Qinlian Decoction
   Jing-Ze Lu et al, 2021, Front. Pharmacol. CrossRef
6. Selenium-Enriched Probiotic Alleviates Western Diet-Induced Non-alcoholic Fatty Liver Disease in Rats via Modulation of Autophagy Through AMPK/SIRT-1 Pathway
   Rajat Pant et al, 2022, Biol Trace Elem Res CrossRef
7. Chrysin Attenuates Fructose-Induced Nonalcoholic Fatty Liver in Rats via Antioxidant and Anti-Inflammatory Effects: The Role of Angiotensin-Converting Enzyme 2/Angiotensin (1-7)/Mas Receptor Axis
   Hala Attia et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
8. Hepatoprotective effect of botanical drug formula on high-fat diet-induced non-alcoholic fatty liver disease by inhibiting lipogenesis and promoting anti-oxidation
   De-Shan Ning et al, 2022, Front. Pharmacol. CrossRef